Literature DB >> 153428

[Immune defect syndrome in Crohn's disease (author's transl)].

K Kleesiek, E Masseck, Z Pusztai-Markos, W Spölgen, T Raguse, H P Bräcker.   

Abstract

In 20 patients suffering for several years from serious chronic relapsing Crohn's disease the following immunological tests were carried out: (1) in-vitro stimulation of blood lymphocytes by PHA-P, (2) identification of T and B cells by formation of spontaneous rosettes and complement receptor rosettes, (3) effect of Crohn's serum on mixed lymphocyte reaction (MLR) of normal allogeneic lymphocytes, (4) in-vitro phagocytosis and intracellular killing of E. coli by polymorphonuclear granulocytes. The results indicate an immune defect of lymphocyte function and the effect of humoral factor(s) on T cell mediated immune reactions: (1) Lymphocyte stimulation by PHA-P was reduced significantly in Crohn's disease. In PHA-P dose response, maximal stimulation has shown a decrease and a shift to higher doses. (2) An increase in the absolute number of B cells caused a decrease in the mean percentage of T cells. The absolute number of T cells did not differ significantly from those of the controls. (3) Crohn's serum has shown an inhibitory effect in MLR of normal lymphocytes. (4) No impairment of phagocytosis or intracellular killing by polymorphonuclear granulocytes has been observed. The results suggest a symptomatic immune defect syndrome in a wasting disease. There is no evidence of a primary immune defect in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 153428     DOI: 10.1007/bf01477078

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  37 in total

1.  Letter: T-cells in Crohn's disease.

Authors:  R G Strickland; R C Williams
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

2.  The mitogenic response of human B lymphocytes to phytohaemagglutinin.

Authors:  B Phillips; E Weisrose
Journal:  Clin Exp Immunol       Date:  1974-03       Impact factor: 4.330

3.  Inhibition of mixed lymphocyte culture by alloantibodies in renal transplantation and in pregnancy.

Authors:  J P Revillard; M Robert; E DuPont; H Betuel; G Rifle; J Traeger
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

4.  Circulating immune complexes in inflammatory bowel disease.

Authors:  D P Jewell; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

5.  Short-term lymphocyte cultures in regional enteritis.

Authors:  S M Brown; R N Taub; D H Present; H D Janowitz
Journal:  Lancet       Date:  1970-05-23       Impact factor: 79.321

6.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  Leukemic serum inhibition of phytohemagglutinin-induced transformation.

Authors:  G B Humphrey; J Lankford; S Oleinick; R Nitschke
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

8.  Lymphocyte responses to nonspecific mitogens in inflammatory bowel disease.

Authors:  P Asquith; S C Kraft; R M Rothberg
Journal:  Gastroenterology       Date:  1973-07       Impact factor: 22.682

9.  Neutrophil dysfunction in Crohn's disease.

Authors:  A W Segal; G Loewi
Journal:  Lancet       Date:  1976-07-31       Impact factor: 79.321

10.  Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions. Influence of anti-leprosy treatment.

Authors:  D S Nelson; J M Penrose; M F Waters; J M Pearson; M Nelson
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.